Capacity of 194 mL with the Ease of OptiSeal, Quick-Seal Tubes
Orange County, Calif. — (May 11, 2011) — The MLA-50 High-Capacity Rotor for the Optima MAX-XP Tabletop Ultracentrifuge from Beckman Coulter, Inc. offers an industry-leading 194 mL capacity that allows more sample to be processed per run. The new aluminum rotor combines with the centrifuge and easy-to-seal tubes to provide highly efficient operation.
Exclusive g-Max tubes adapt small samples to the larger MLA-50 without sacrificing the g-force generated by the rotor, shortening separation time by up to 20 percent. The rotor also accepts OptiSeal tubes, which do not require tools, heat or closure verification and have a wide neck that makes it easy to load and unload samples without puncturing the tube. Quick-Seal tubes, which seal with a simple, hand-held tool and do not incorporate plugs or O-rings, can also be used.
The MLA-50 rotor runs exclusively on Beckman Coulter’s Optima MAX-XP Tabletop Ultracentrifuge, providing quiet performance, a customizable interface supporting multiple users, a compact footprint and instant, context-sensitive on-board help. Nine native languages — including Japanese, Spanish, simplified Chinese and English — are available via menu selection.
“The MLA-50 rotor reflects the Beckman Coulter commitment to developing products that enhance productivity and lab performance for our customers,” said Randy Pawlovich, strategic marketing manager for the Beckman Coulter ultracentrifuge product line. “As a worldwide leader in centrifugation, we’re able to offer researchers an extensive catalog featuring products to meet virtually all centrifugation requirements.”
The Optima MAX-XP Tabletop Ultracentrifuge is one of the most flexible benchtop ultracentrifuges and the versatile platform — on which labware, rotors and centrifuges are manufactured and tested as an integrated system — ensures optimal performance and safety.
About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, Calif., develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 275,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of consumable supplies (including reagent test kits), service and operating-type lease payments, represents about 80 percent of the company’s 2010 revenue of $3.7 billion. For more information, visit www.beckmancoulter.com.
Celeste Speier, Beckman Coulter, Inc., Public Relations
Phone: (714) 961-6436
E-mail: [email protected]
Steve Ernst, Veris Communications
Phone: (973) 702-7249
E-mail: [email protected]